SCHEMBL662471

SCHEMBL662471

CCOCC(O)(c1ccccc1)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.44
SIGMAR1 Q99720 1/20 0.43
MAPK1 P28482 1/20 0.41
CHRM2 P08172 4/20 0.41
CHRM1 P11229 4/20 0.41
CHRM4 P08173 3/20 0.41
CHRM5 P08912 3/20 0.41
CHRM3 P20309 3/20 0.41
CYP2D6 P10635 2/20 0.41
LMNA P02545 1/20 0.41
HTR1A P08908 1/20 0.41
OPRM1 P35372 1/20 0.41
KCNH2 Q12809 1/20 0.41
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
ALDH1A1 P00352 1/20 0.39
ALOX15 P16050 1/20 0.39
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
CYP1A2 P05177 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9647561 0.87 SMN1; SMN2 (0.45) SMN1; SMN2SIGMAR1MAPK1CHRM2CHRM1
SCHEMBL8911590 0.83 CYP1A2 (0.47) SMN1; SMN2SIGMAR1MAPK1CHRM3MEN1
SCHEMBL14269138 0.83 MAPK1 (0.44) SMN1; SMN2SIGMAR1MAPK1KCNH2ALDH1A1
SCHEMBL433468 0.80 NPSR1 (0.49) SMN1; SMN2MAPK1CHRM3CYP2D6LMNA
SCHEMBL14288445 0.80 SMN1; SMN2 (0.50) SMN1; SMN2SIGMAR1MAPK1CHRM2CHRM1
SCHEMBL29097238 0.79 KMT2A (0.42) SMN1; SMN2MAPK1CHRM2CHRM1CHRM4
Triphenylmethanol SCHEMBL10722183 0.78 ACSS2 (0.42) SMN1; SMN2MAPK1KMT2AALDH1A1ALOX15
SCHEMBL19884937 0.78 SMN1; SMN2 (0.47) SMN1; SMN2SIGMAR1MAPK1CHRM2CHRM1
Ether SCHEMBL4375756 0.78 CYP2C19 (0.47) SMN1; SMN2SIGMAR1MAPK1CYP2D6LMNA
SCHEMBL11497301 0.77 MAPK1 (0.48) MAPK1CYP2D6MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2351730-B1 ETHOXY DIPHENYL ETHANE DERIVATES, PREPARATION PROCESSES AND USES THEREOF SHANGHAI ECUST BIOMEDICINE CO LTD (CN) 2014-07-30 EP claimed
US-20120046492-A1 Ethoxy Diphenyl Ethane Derivatives, Preparation Processes and Uses Thereof Zhejiang Wild Wind Pharmaceutical Co., Ltd. (CN) 2012-02-23 US claimed
EP-2351730-A1 ETHOXY DIPHENYL ETHANE DERIVATES, PREPARATION PROCESSES AND USES THEREOF Shanghai Ecust Biomedicine Co., Ltd (CN) 2011-08-03 EP claimed
EP-2351730-B1 ETHOXY DIPHENYL ETHANE DERIVATES, PREPARATION PROCESSES AND USES THEREOF SHANGHAI ECUST BIOMEDICINE CO LTD (CN) 2014-07-30 EP disclosed
US-20120046492-A1 Ethoxy Diphenyl Ethane Derivatives, Preparation Processes and Uses Thereof Zhejiang Wild Wind Pharmaceutical Co., Ltd. (CN) 2012-02-23 US disclosed
EP-2351730-A1 ETHOXY DIPHENYL ETHANE DERIVATES, PREPARATION PROCESSES AND USES THEREOF Shanghai Ecust Biomedicine Co., Ltd (CN) 2011-08-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046492-A1 Ethoxy Diphenyl Ethane Derivatives, Preparation Processes and Uses Thereof TUBB1, TUBB, TUBB3 SMN1; SMN2 4580/4885SIGMAR1 1134/4885MAPK1 1176/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.